Interplay of SOX transcription factors and microRNAs in the brain under physiological and pathological conditionsMilena Stevanovic，Danijela Stanisavljevic Ninkovic，Marija Mojsin，Danijela Drakulic，Marija Schwirtlich2325-2334
Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegenerationRangariroyashe H.Chipika，Grainne Mulkerrin，Pierre-François Pradat，Aizuri Murad，Fabrice Ango，Cédric Raoul，Peter Bede2335-2341
Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer 's diseaseEkta Bajwa，Andis Klegeris2342-2346
An atypical ubiquitin ligase at the heart of neural development and programmed axon degenerationSatpal Virdee2347-2350
The endogenous progenitor response following traumatic brain injury: a target for cell therapy paradigmsAnna Badner，Brian J.Cummings2351-2354
The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer 's diseaseYan-Li Zhang，Juan Wang，Zhi-Na Zhang，Qiang Su，Jun-Hong Guo2355-2363
MicroRNAs as biomarkers in glaucoma and potential therapeutic targetsBridget Martinez，Philip V.Peplow2368-2375
Neuroprotection and neuroregeneration: roles for the white matterVito Antonio Baldassarro，Agnese Stanzani，Luciana Giardino，Laura Calzà，Luca Lorenzini2376-2380
Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer 's disease: a meta-analysis and systematic reviewWei-Lin Liu，Hua-Wei Lin，Miao-Ran Lin，Yan Yu，Huan-Huan Liu，Ya-Ling Dai，Le-Wen Chen，Wei-Wei Jia，Xiao-Jun He，Xiao-Ling Li，Jing-Fang Zhu，Xie-Hua Xue，Jing Tao，Li-Dian Chen2381-2390
